Ye, D., Mendelsohn, J., and Fan, Z. (1999) Androgen and epidermal growth factor down-regulate cyclin-dependent kinase inhibitor p27Kip1 and costimulate proliferation of MDA PCa 2a and MDA PCa 2b prostate cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research 5, 2171-2177

Ye, D., Mendelsohn, J., and Fan, Z. (1999) Augmentation of a humanized anti-HER2 mAb 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225. Oncogene 18, 731-738

Dai, B., Ye, D. W., Kong, Y. Y., Yao, X. D., Zhang, H. L., and Shen, Y. J. (2006) Predicting regional lymph node metastasis in Chinese patients with penile squamous cell carcinoma: the role of histopathological classification, tumor stage and depth of invasion. The Journal of urology 176, 1431-1435; discussion 1435

Zhu, Y., Zhou, X. Y., Yao, X. D., Dai, B., and Ye, D. W. (2007) The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery. BJU international 100, 204-208

Cao, D. L., Ye, D. W., Zhang, H. L., Zhu, Y., Wang, Y. X., and Yao, X. D. (2011) A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer. The Prostate 71, 700-710

Xu, J., Mo, Z., Ye, D., Wang, M., Liu, F., Jin, G., Xu, C., Wang, X., Shao, Q., Chen, Z., Tao, Z., Qi, J., Zhou, F., Wang, Z., Fu, Y., He, D., Wei, Q., Guo, J., Wu, D., Gao, X., Yuan, J., Wang, G., Xu, Y., Wang, G., Yao, H., Dong, P., Jiao, Y., Shen, M., Yang, J., Ou-Yang, J., Jiang, H., Zhu, Y., Ren, S., Zhang, Z., Yin, C., Gao, X., Dai, B., Hu, Z., Yang, Y., Wu, Q., Chen, H., Peng, P., Zheng, Y., Zheng, X., Xiang, Y., Long, J., Gong, J., Na, R., Lin, X., Yu, H., Wang, Z., Tao, S., Feng, J., Sun, J., Liu, W., Hsing, A., Rao, J., Ding, Q., Wiklund, F., Gronberg, H., Shu, X. O., Zheng, W., Shen, H., Jin, L., Shi, R., Lu, D., Zhang, X., Sun, J., Zheng, S. L., and Sun, Y. (2012) Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4. Nature genetics 44, 1231-1235

Ye, L., Li, S., Ye, D., Yang, D., Yue, F., Guo, Y., Chen, X., Chen, F., Zhang, J., and Song, X. (2013) Livin expression may be regulated by miR-198 in human prostate cancer cell lines. European journal of cancer (Oxford, England : 1990) 49, 734-740

Zhu, Y., Zhou, X. Y., Yao, X. D., Zhang, S. L., Dai, B., Zhang, H. L., Shen, Y. J., and Ye, D. W. (2013) Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: a pilot study. Urologic oncology 31, 706-711

Zhu, Y., and Ye, D. W. (2014) Prostate cancer: alkaline phosphatase velocity in nonmetastatic CRPC. Nature reviews. Urology 11, 666-667

Gu, W., Zhang, G., Sun, L., Ma, Q., Cheng, Y., Zhang, H., Shi, G., Zhu, Y., and Ye, D. (2015) Nutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinoma. Journal of cachexia, sarcopenia and muscle 6, 222-230

Li, F., He, X., Ye, D., Lin, Y., Yu, H., Yao, C., Huang, L., Zhang, J., Wang, F., Xu, S., Wu, X., Liu, L., Yang, C., Shi, J., He, X., Liu, J., Qu, Y., Guo, F., Zhao, J., Xu, W., and Zhao, S. (2015) NADP(+)-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance. Molecular cell 60, 661-675

Li, Q., Gu, C., Zhu, Y., Wang, M., Yang, Y., Wang, J., Jin, L., Zhu, M. L., Shi, T. Y., He, J., Ye, D., and Wei, Q. (2015) Two novel PRKCI polymorphisms and prostate cancer risk in an Eastern Chinese Han population. Molecular carcinogenesis 54, 632-641

Zhu, Y., Dai, B., Zhang, H., Shi, G., Shen, Y., and Ye, D. (2016) Long non-coding RNA LOC572558 inhibits bladder cancer cell proliferation and tumor growth by regulating the AKT-MDM2-p53 signaling axis. Cancer letters 380, 369-374

Wan, F., Zhu, Y., Han, C., Xu, Q., Wu, J., Dai, B., Zhang, H., Shi, G., Gu, W., and Ye, D. (2017) Identification and validation of an eight-gene expression signature for predicting high Fuhrman grade renal cell carcinoma. International journal of cancer 140, 1199-1208

Fu, H., Zhu, Y., Wang, Y., Liu, Z., Zhang, J., Wang, Z., Xie, H., Dai, B., Xu, J., and Ye, D. (2017) Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma. Annals of surgical oncology 24, 1435-1442

Tang, B., Han, C. T., Zhang, G. M., Zhang, C. Z., Yang, W. Y., Shen, Y., Vidal, A. C., Freedland, S. J., Zhu, Y., and Ye, D. W. (2017) Waist-hip Ratio (WHR), a Better Predictor for Prostate Cancer than Body Mass Index (BMI): Results from a Chinese Hospital-based Biopsy Cohort. Scientific reports 7, 43551

Wang, Y., Dai, B., and Ye, D. W. (2017) Serum testosterone level predicts the effective time of androgen deprivation therapy in metastatic prostate cancer patients. Asian journal of andrology 19, 178-183

Qu, Y., Gu, C., Wang, H., Chang, K., Yang, X., Zhou, X., Dai, B., Zhu, Y., Shi, G., Zhang, H., and Ye, D. (2016) Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population. Scientific reports 6, 21677

Zhu, Y. P., Wan, F. N., Shen, Y. J., Wang, H. K., Zhang, G. M., and Ye, D. W. (2015) Reactive stroma component COL6A1 is upregulated in castration-resistant prostate cancer and promotes tumor growth. Oncotarget 6, 14488-14496